A study being presented at the ANA 2019 annual meeting highlights the connection between primary progressive aphasia and Alzheimer disease. Speaker and lead researcher Marek-Marsel Mesulam, MD, answers our...
In this podcast, Shane Liddelow, PhD, from NYU Langone Health, discusses his latest research on astrocytes—a topic he also spoke about at the Alzheimer's Association International Conference 2019.
In this commentary, Dr Rebecca Gottesman reviews the results of her ARIC-PET amyloid imaging study and explains what they mean for the future of clinical practice.
Dr David Llewellyn from the University of Exeter Medical School answers our questions about his research on dementia misclassification when using brief cognitive assessments.
Marylyn Ritchie, PhD, discusses how genome sequencing can help patients learn about their family history, their risk levels for certain diseases, and their likely responses to a variety of drug treatments.
...
Michael Gordon, MD, shares clinical advice for engaging with patients who have cognitive concerns ranging from subjective cognitive impairment to dementia.
Stevin Zorn, PhD, discusses research into exploitation of a single mechanism of action for possible treatment and prevention of Alzheimer disease, and a possible shift of focus towards experimenting with...
Alison Goate, DPhil, answered our questions about her research on the role of genetics in Alzheimer disease onset, a topic she will also be presenting at 144th Annual Meeting of the American Neurological...
